Found: 48
Select item for more details and to access through your institution.
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 4, p. 761, doi. 10.1007/s10096-020-04078-1
- By:
- Publication type:
- Article
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 743, doi. 10.3390/jpm12050743
- By:
- Publication type:
- Article
Perception of stigma in patients with primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 2, p. 1, doi. 10.1177/2055217319852717
- By:
- Publication type:
- Article
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1399, doi. 10.3390/vaccines11091399
- By:
- Publication type:
- Article
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 786, doi. 10.3390/vaccines11040786
- By:
- Publication type:
- Article
Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.798003
- By:
- Publication type:
- Article
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis.
- Published in:
- Frontiers in Neurology, 2024, p. 01, doi. 10.3389/fneur.2024.1371644
- By:
- Publication type:
- Article
Emerging biomarkers for improving pregnancy planning in multiple sclerosis.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1292296
- By:
- Publication type:
- Article
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 713, doi. 10.2147/PPA.S305707
- By:
- Publication type:
- Article
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 4, p. 1, doi. 10.1002/brb3.2044
- By:
- Publication type:
- Article
Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1317, doi. 10.1177/1352458517717088
- By:
- Publication type:
- Article
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 6, p. 690, doi. 10.1177/1352458510396922
- By:
- Publication type:
- Article
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat<sup>®</sup> Methodology.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.722801
- By:
- Publication type:
- Article
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 3, p. 231, doi. 10.1007/s40263-024-01066-3
- By:
- Publication type:
- Article
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study.
- Published in:
- CNS Drugs, 2020, v. 34, n. 12, p. 1275, doi. 10.1007/s40263-020-00775-9
- By:
- Publication type:
- Article
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0255317
- By:
- Publication type:
- Article
Estudios de práctica clínica real en esclerosis múltiple.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2021, v. 45, n. 2, p. 51, doi. 10.7399/fh.11663
- By:
- Publication type:
- Article
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03077-9
- By:
- Publication type:
- Article
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non‐cell‐autonomous neuronal damage.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.837
- By:
- Publication type:
- Article
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1288169
- By:
- Publication type:
- Article
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1248182
- By:
- Publication type:
- Article
Molecular signature associated with cladribine treatment in patients with multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1233546
- By:
- Publication type:
- Article
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 355, doi. 10.1002/acn3.711
- By:
- Publication type:
- Article
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.760546
- By:
- Publication type:
- Article
Consensus on early detection of disease progression in patients with multiple sclerosis.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.931014
- By:
- Publication type:
- Article
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
- Published in:
- Journal of Clinical Immunology, 2021, v. 41, n. 2, p. 315, doi. 10.1007/s10875-020-00927-y
- By:
- Publication type:
- Article
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
- Published in:
- Annals of Neurology, 2015, v. 77, n. 3, p. 447, doi. 10.1002/ana.24345
- By:
- Publication type:
- Article
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 8, p. 2362, doi. 10.1007/s00415-020-09848-7
- By:
- Publication type:
- Article
Does normal substantia nigra echogenicity make a difference in Parkinson’s disease diagnosis? A real clinical practice follow-up study.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 10, p. 2363, doi. 10.1007/s00415-018-9006-5
- By:
- Publication type:
- Article
Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 1, p. 24, doi. 10.1007/s00415-017-8625-6
- By:
- Publication type:
- Article
Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.
- Published in:
- 2018
- By:
- Publication type:
- Erratum
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88624-7
- By:
- Publication type:
- Article
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71283-5
- By:
- Publication type:
- Article
The Broad Concept of "Spasticity-Plus Syndrome" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00152
- By:
- Publication type:
- Article
Risk and outcomes of COVID‐19 in patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 11, p. 3712, doi. 10.1111/ene.14990
- By:
- Publication type:
- Article
Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 540, doi. 10.3390/biomedicines8120540
- By:
- Publication type:
- Article
Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 119, doi. 10.3390/cells10010119
- By:
- Publication type:
- Article
Biomarcadores en esclerosis múltiple y otras enfermedades desmielinizantes.
- Published in:
- Kranion, 2019, v. 14, n. 2, p. 52
- By:
- Publication type:
- Article
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 3, p. 1101, doi. 10.1007/s40120-022-00356-6
- By:
- Publication type:
- Article
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1439393
- By:
- Publication type:
- Article
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1454474
- By:
- Publication type:
- Article
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1384411
- By:
- Publication type:
- Article
Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 10, p. 1341, doi. 10.1177/13524585241272960
- By:
- Publication type:
- Article
Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1393, doi. 10.1177/13524585231195851
- By:
- Publication type:
- Article
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 18, p. 10012, doi. 10.3390/ijms251810012
- By:
- Publication type:
- Article
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7808, doi. 10.3390/ijms25147808
- By:
- Publication type:
- Article
Comparative Diagnostic Accuracy of Ganglion Cell-Inner Plexiform and Retinal Nerve Fiber Layer Thickness Measures by Cirrus and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/128517
- By:
- Publication type:
- Article